ABHD17AP5

Across TCGA pan-cancer cohorts, ABHD17AP5 RNA is linked to patient survival in 20 of 34 cancer types, making it the most broadly survival-associated ABHD17AP5 data layer.

The strongest signal is observed in esophageal carcinoma (ESCA), where higher ABHD17AP5 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated ABHD17AP5 expression acts as an unfavorable survival marker, although some lineages such as ESCA and SKCM show a favorable association.

ESCA, SKCM, and UCEC are the cancer types where ABHD17AP5 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ESCA	DFS	Median	II,III,IV	0.626	0.416	.003	61	view →
SKCM	OS	Quartile	II,III,IV	0.833	0.684	.005	35	view →
UCEC	DFS	Median	IV	0.673	0.267	.007	32	view →
LUAD	DFS	Median	All	0.828	0.752	.005	30	view →
UVM	DFS	Quartile	All	0.259	0.892	<.001	20	view →
READ	DFS	Median	IV	0.792	0.329	.003	16	view →
MESO	DFS	Median	III,IV	0.297	0.489	.010	12	view →
KIRP	OS	Tertile	III,IV	0.675	0.902	.022	12	view →
KIRC	DFS	Median	III,IV	0.709	0.580	.010	12	view →
HNSC	DFS	Tertile	III,IV	0.761	0.606	.006	12	view →
DLBC	DFS	Tertile	All	0.614	1.000	.002	10	view →
PAAD	DFS	Tertile	II,III,IV	0.251	0.505	.005	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 20 lineages.

ABHD17AP5–ESCA (DFS)

Open the ESCA breakdown →